Dose- and time-dependence of L-NAME neuroprotection in transient focal cerebral ischaemia in rats

British Journal of Pharmacology

Volumn 120, Issue 1, 1997, Pages 160-163

  Margaill, Isabelle ^a   Allix, Monique ^a   Boulu, Roger G ^a   Plotkine, Michel ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Focal cerebral ischaemia; Ischaemia reperfusion; N(G) nitro L arginine methyl ester (L NAME); Nitric oxide

Indexed keywords

DIZOCILPINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN INFARCTION; BRAIN ISCHEMIA; CONTROLLED STUDY; CORPUS STRIATUM; DOSE TIME EFFECT RELATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031034916     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0700889     Document Type: Article

References (23)

1. ASHWAL, S., COLE, D.J., OSBORNE, T.N. & PEARCE, W.J. (1993). Low dose L-NAME reduces infarct volume in the rat MCAO/ reperfusion model. J. Neurosurg. Anesthesiol., 5, 241-249.
2. BUISSON, A., MARGAILL, I., CALLEBERT, J., PLOTKINE, M. & BOULU, R.G. (1993). Mechanisms involved in the neuroprotective activity of a nitric oxide synthase inhibitor during focal cerebral ischaemia. J. Neurochem., 61, 690-696.
3. BUISSON, A., PLOTKINE, M. & BOULU, R.G. (1992). The neuroprotective effect of a nitric oxide synthase inhibitor in a rat model of focal cerebral ischaemia. Br. J. Pharmacol., 106, 766-767.
4. DAWSON, V.L., DAWSON, T.M., LONDON, E.D., BREDT, D.S. & SNYDER, S.H. (1991). Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. U.S.A., 88, 6368-6371.
5. GARTHWAITE, J., CHARLES, S.L. & CHESS-WILLIAMS, R. (1988). Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature, 336, 385-387.
6. GOLANOV, E.V. & REIS, D.J. (1995). Contribution of cerebral edema to the neuronal salvage elicited by stimulation of cerebellar fastigial nucleus after occlusion of the middle cerebral artery in rat. J. Cereb. Blood Flow Metab., 15, 172-174.
7. HUANG, Z., HUANG, P.L., PANAHIAN, N., DALKARA, T., FISHMAN, M.C. & MOSKOWITZ, M.A. (1994). Effects of cerebral ischaemia in mice deficient in neuronal nitric oxide synthase. Science, 265, 1883-1885.
8. IADECOLA, C., XU, X., ZHANG, F., CASEY, R., CLARK, H.B. & ROSS, M.E. (1995a). Inducible nitric oxide synthase gene expression in transient focal cerebral ischaemia: protection by aminoguanidine. Soc. Neurosci. Abstr., 21, Part 2, 1031.
9. IADECOLA, C., XU, X., ZHANG, F., HU, J. & EL-FAKAHANY, E.E. (1994). Prolonged inhibition of brain nitric oxide synthase by short-term systemic administration of nitro-L-aginine methyl ester. Neurochem. Res., 19, 501-505.
10. IADECOLA, C., ZHANG, F., XU, S., CASEY, R. & ROSS, M.E. (1995b). Inducible nitric oxide synthase gene expression in brain following cerebral ischaemia. J. Cereb. Blood Flow Metab., 15, 378-384.
11. KUBES, P. (1995). Nitric oxide modulates leukocyte function in ischaemia/reperfusion. In Nitric Oxide: a Modulator of Cell-Cell Interactions in the Microcirculation, ed. Kubes, P. pp. 101-126. Austin: R.G. Landes Company.
12. KUBES, P., SUZUKI, M. & GRANGER, D.N. (1991). Nitric oxide: an endogenous modulator of leukocytes adhesion. Proc. Natl. Acad. Sci. U.S.A., 88, 4651-4655.
13. KULUZ, J.W., PRADO, R.J., DIETRICH, W.D., SCHLEIEN, C.L. & WATSON, B.D. (1993). The effect of nitric oxide synthase inhibition on infarct volume after reversible focal cerebral ischaemia in conscious rats. Stroke, 24, 2023-2029.
14. MARGAILL, I., PARMENTIER, S., CALLEBERT, J., ALLIX, M., BOULU, R.G. & PLOTKINE, M. (1996). Short therapeutic window for MK-801 in transient focal cerebral ischaemia in normotensive rats. J. Cereb. Blood Flow Metab., 16, 107-113.
15. MOILANEN, E., VUORINEN P, KANKAANRATA, H. METSÄ-KETELÄ, T. & VAPAATALO, H. (1993). Inhibition by nitric oxide-donors of human polymorphonuclear leucocyte functions. Br. J. Pharmacol., 109, 852-858.
16. MORIKAWA, E., MOSKOWITZ, M., HUANG, Z., YOSHIDA T, IRIKURA, K. & DALKARA, T. (1994). L-arginine infusion promotes nitric oxide-dependent vasodilatation, increases regional cerebral blood flow, and reduces infarction volume in the rat. Stroke, 25, 429-435.
17. NAGAFUJI, T., SUGIYAMA, M. & MATSUI, T. (1994). Temporal profiles of Ca2+/calmodulin-dependent and -independent nitric oxide synthase activity in the rat brain microvessels following cerebral ischaemia. Acta Neurochir., 60, 285-288.
18. NAGAFUJI, T., SUGIYAMA, M., MUTO, A., MAKINO, T., MIYAUCHI, T. & NABATA, H. (1995). The neuroprotective effect of a potent and selective inhibitor of type I NOS (L-MIN) in a rat model of focal cerebral ischaemia. Neuroreport, 6, 1541-1545.
19. UCHIYAMA-TSUYUKI, Y., ARAKI, H., YAE, T. & OTOMO, S. (1994). Changes in the extracellular concentrations of amino-acids in the rat striatum during transient focal cerebral ischaemia. J. Neurochem., 62, 1074-1078.
20. VERRECCHIA, C., BOULU, R.G. & PLOTKINE, M. (1995). Neuroprotective and deleterious effects of nitric oxide on focal cerebral ischaemia-induced neurone death. Adv. Neuroimmunol., 5, 359-378.
21. YOSHIDA, T., LIMMROTH, V., IRIKURA, K. & MOSKOWITZ, M.A. (1994). The NOS inhibitor, 7-nitroindazole, decreases focal infarct volume but not the response to topical acetylcholine in pial vessels. J. Cereb. Blood Flow Metab., 14, 924-929.
22. ZHANG, F. WHITE, J.G. & IADECOLA, C. (1994). Nitric oxide donors increase blood flow and reduce brain damage in focal cerebral ischaemia: evidence that nitric oxide is beneficial in the early stages of cerebral ischaemia. J. Cereb. Blood Flow Metab., 14, 217-226.
23. ZHANG, F., XU, S. & IADECOLA, C. (1995). Time dependence of effect of nitric oxide synthase inhibition on cerebral ischemic damage. J. Cereb. Blood Flow Metab., 15, 595-601.